BioCentury
ARTICLE | Company News

Gilead acquires cicletanine assets

May 30, 2008 12:42 AM UTC

Gilead (NASDAQ:GILD) acquired from Navitas (Laramie, Wyo.) assets related to cicletanine, an off-patent diuretic. Navitas received an undisclosed upfront payment and also is eligible for milestones an...